Literature DB >> 3319457

Clinical activity assessment in inflammatory bowel disease.

J W Singleton1.   

Abstract

Standardized methods of making and recording clinical observations of patients with inflammatory bowel disease are needed for the conduct of controlled clinical trials and for the application of the results of such trials to clinical practice. A number of attempts to develop such methods have been made since the early 1950s, and such efforts continue at present. A universally accepted and acceptable clinical instrument to measure the disease activity of either Crohn's disease or ulcerative colitis will probably never be achieved. However, if interested clinicians can agree on a basic set of observations and how to make and record them, accurate comparisons of therapeutic outcomes across time and space will become possible. Toward this goal several groups of clinicians are currently working.

Entities:  

Mesh:

Year:  1987        PMID: 3319457     DOI: 10.1007/BF01312462

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  11 in total

1.  Cortisone in ulcerative colitis; final report on a therapeutic trial.

Authors:  S C TRUELOVE; L J WITTS
Journal:  Br Med J       Date:  1955-10-29

2.  Chemotherapy of pulmonary tuberculosis in young adults; an analysis of the combined results of three Medical Research Council trials.

Authors:  M DANIELS; A B HILL
Journal:  Br Med J       Date:  1952-05-31

3.  A simple index of Crohn's-disease activity.

Authors:  R F Harvey; J M Bradshaw
Journal:  Lancet       Date:  1980-03-08       Impact factor: 79.321

Review 4.  Laboratory assessment of inflammatory bowel disease.

Authors:  I T Beck
Journal:  Dig Dis Sci       Date:  1987-12       Impact factor: 3.199

5.  A simple clinical index of Crohn's disease activity--the Cape Town index.

Authors:  J P Wright; I N Marks; A Parfitt
Journal:  S Afr Med J       Date:  1985-09-28

6.  Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study.

Authors:  W R Best; J M Becktel; J W Singleton; F Kern
Journal:  Gastroenterology       Date:  1976-03       Impact factor: 22.682

7.  The O.M.G.E. Multinational Inflammatory Bowel Disease Survey 1976-1982. A further report on 2,657 cases.

Authors:  J Myren; I A Bouchier; G Watkinson; A Softley; S E Clamp; F T de Dombal
Journal:  Scand J Gastroenterol Suppl       Date:  1984

8.  A comparison of oral prednisolone given as single or multiple daily doses for active proctocolitis.

Authors:  J Powell-Tuck; R L Bown; J E Lennard-Jones
Journal:  Scand J Gastroenterol       Date:  1978       Impact factor: 2.423

9.  Treatment of Crohn's disease with 6-mercaptopurine. A long-term, randomized, double-blind study.

Authors:  D H Present; B I Korelitz; N Wisch; J L Glass; D B Sachar; B S Pasternack
Journal:  N Engl J Med       Date:  1980-05-01       Impact factor: 91.245

10.  Rederived values of the eight coefficients of the Crohn's Disease Activity Index (CDAI).

Authors:  W R Best; J M Becktel; J W Singleton
Journal:  Gastroenterology       Date:  1979-10       Impact factor: 22.682

View more
  6 in total

1.  Ulcerative colitis: an overview.

Authors:  A Archambault
Journal:  Can Fam Physician       Date:  1990-02       Impact factor: 3.275

2.  Magnetic resonance imaging of the small bowel in children with idiopathic inflammatory bowel disease: evaluation of disease activity.

Authors:  Efthymia Alexopoulou; Eleftheria Roma; Dimitra Loggitsi; Nikos Economopoulos; Olympia Papakonstantinou; Ioanna Panagiotou; Ioanna Pahoula; Nikolaos L Kelekis
Journal:  Pediatr Radiol       Date:  2009-05-19

3.  Polymeric enteral diets as primary treatment of active Crohn's disease: a prospective steroid controlled trial.

Authors:  F González-Huix; R de León; F Fernández-Bañares; M Esteve; E Cabré; D Acero; A Abad-Lacruz; M Figa; M Guilera; R Planas
Journal:  Gut       Date:  1993-06       Impact factor: 23.059

4.  A novel population of human CD56+ human leucocyte antigen D-related (HLA-DR+) colonic lamina propria cells is associated with inflammation in ulcerative colitis.

Authors:  S C Ng; S Plamondon; H O Al-Hassi; N English; N Gellatly; M A Kamm; S C Knight; A J Stagg
Journal:  Clin Exp Immunol       Date:  2009-08-12       Impact factor: 4.330

5.  Clinical subtypes of Crohn's disease according to surgical outcome.

Authors:  S E Greenway; M A Buckmire; C Marroquin; L Jadon; R H Rolandelli
Journal:  J Gastrointest Surg       Date:  1999 Mar-Apr       Impact factor: 3.267

6.  Magnetic resonance enterography predicts the prognosis of Crohn's disease.

Authors:  Ji Hoon Lee; Yong Eun Park; Nieun Seo; Hyun Jung Lee; Soo Jung Park; Tae Il Kim; Won Ho Kim; Joon Seok Lim; Jae Hee Cheon
Journal:  Intest Res       Date:  2018-07-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.